Clinical Trial Update: Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating GRN163L (imetelstat) in combination with paclitaxel and carboplatin in patients with advanced or metastatic non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• GRN163L (imetelstat)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Geron Corporation | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED